The use of dupilumab in severe atopic dermatitis during pregnancy: a case report

BACKGROUND: Atopic dermatitis is a common chronic skin disease that can occur in pregnancy. Current treatments include topical and systemic glucocorticoids and cyclosporine. Presently, the only biologic approved for atopic dermatitis is dupilumab with limited data available regarding its safety prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtar, Nabeel H., Khosravi-Hafshejani, Touraj, Akhtar, Daud, Dhadwal, Gurbir, Kanani, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815205/
https://www.ncbi.nlm.nih.gov/pubmed/35115035
http://dx.doi.org/10.1186/s13223-022-00650-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815205/
https://www.ncbi.nlm.nih.gov/pubmed/35115035
http://dx.doi.org/10.1186/s13223-022-00650-w

Ejemplares similares